Medicare Enrolled

Dr. David Shusterman, M.D.

Urology Physician · New York, NY
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
800 2ND AVE, New York, NY 10017
2129919991
In practice since 2007 (19 years)
NPI: 1215138342 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Shusterman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Shusterman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Shusterman

Dr. David Shusterman is an urology physician in New York, NY, with 19 years of NPI registration. Based on federal Medicare data, Dr. Shusterman performed 6,361 Medicare services across 4,098 unique beneficiaries.

Between the years covered by Open Payments, Dr. Shusterman received a total of $9,925 from 53 pharmaceutical and/or device companies across 174 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Shusterman is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 14% volume in NY $9,925 industry payments

Medicare Practice Summary

Medicare Utilization ↗
6,361
Medicare services
Top 14% in NY for urology physician
4,098
Unique beneficiaries
$38
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~335 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
684 $3 $30
Electronic assessment of bladder emptying
A test that uses electronic monitoring to evaluate how well the bladder empties urine.
629 $11 $306
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
592 $82 $213
Bladder ultrasound after voiding
An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder.
397 $10 $125
Office visit, established patient (10-19 min)
An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition.
288 $50 $132
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
231 $8 $30
Free PSA test
A blood test that measures the amount of unbound prostate-specific antigen in the blood.
206 $18 $75
PSA test (prostate cancer screening) 204 $18 $100
Lower leg neurostimulator electrode insertion
A procedure to place an electrode in the lower leg for neurostimulation therapy.
203 $107 $350
Comprehensive metabolic blood panel
A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers.
202 $10 $150
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
200 $8 $100
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
194 $68 $150
Total testosterone level test
A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women.
181 $25 $121
Free testosterone level test
A blood test that measures the amount of free testosterone in your body. Free testosterone is the portion of the hormone not bound to proteins and available for use by tissues.
176 $25 $121
Total estradiol level test
A blood test that measures the total amount of estradiol, a form of estrogen, in the body.
148 $27 $101
Ferritin level test (iron stores)
A blood test that measures the level of ferritin, a protein that stores iron in the body.
147 $13 $130
Folic acid level test
A blood test that measures the amount of folic acid in the serum.
147 $14 $100
Vitamin D level test
A blood test to measure the amount of Vitamin D-3 in your body.
146 $29 $129
Vitamin B-12 level test
A blood test that measures the amount of vitamin B-12 in your body.
146 $15 $100
Iron level test 146 $6 $75
Iron binding capacity test
A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron.
146 $9 $119
New patient office visit (30-44 min)
An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range.
114 $103 $321
Electrolyte blood test panel
A blood test that measures the levels of sodium, potassium, chloride, and carbon dioxide to evaluate electrolyte balance.
111 $7 $75
Non-needle muscle activity measurement of bladder and bowel openings
This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles.
87 $30 $755
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
78 $80 $185
Complex urodynamic pressure flow study
A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning.
75 $339 $850
SARS-CoV-2 immunoassay test
A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus.
68 $35 $300
Cell examination with selective cellular enhancement
A laboratory test that examines cells from a specimen using a technique to selectively enhance specific cellular features for detailed analysis.
63 $23 $850
Manual urine cell examination
A laboratory test where a technician manually examines a urine sample under a microscope to identify and count cells.
62 $58 $3,100
Cystourethroscopy
A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract.
60 $206 $773
Hemoglobin A1c test (diabetes monitoring)
A blood test that measures your average blood sugar levels over the past two to three months.
36 $10 $112
Hormone pellet insertion under the skin
A small hormone pellet is placed just beneath the skin to release medication slowly over time.
35 $87 $571
Sex hormone binding globulin level test
A blood test that measures the level of sex hormone binding globulin, a protein that binds to sex hormones in the bloodstream.
24 $21 $83
New patient office visit, 15-29 minutes
An initial office visit for a new patient lasting 15 to 29 minutes. This code is used when the total time spent on the date of the encounter meets this duration threshold.
23 $67 $225
Thyroid stimulating hormone (TSH) test
A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function.
20 $16 $150
Assessment of muscle signal of pelvic nerves
This procedure evaluates the electrical activity or signal of muscles innervated by the pelvic nerves. It is used to assess the functional status of these nerves and the muscles they control.
18 $261 $832
Follicle stimulating hormone (FSH) level
A blood test to measure the level of follicle stimulating hormone, a reproductive hormone.
17 $18 $75
Luteinizing hormone level test
A blood test that measures the level of luteinizing hormone, a reproductive hormone. This test helps evaluate hormonal balance and reproductive function.
17 $18 $250
Urethral dilation using endoscope
A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage.
16 $271 $1,147
Complex urodynamic pressure measurement
A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures.
12 $367 $1,146
Abdominal device insertion with pressure and urine flow study
A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate.
12 $185 $568
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$9,925
Total received (2018-2024)
Avg $1,418/year across 7 years
Top 18% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
53
Companies
174
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,078 (51.2%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$4,687 (47.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$161 (1.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,125
2023
$771
2022
$5,832
2021
$597
2020
$173
2019
$915
2018
$513

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AngioDynamics, Inc.
$174
Astellas Pharma US Inc
$161
Endo USA, Inc.
$125
Curonix LLC
$118
Evofem Biosciences, Inc.
$92
Hologic Sales and Service, LLC
$63
MAYNE PHARMA COMMERCIAL LLC
$57
Tolmar, Inc.
$48
Sumitomo Pharma America, Inc.
$45
Agile Therapeutics, Inc.
$43
Phathom Pharmaceuticals, Inc.
$27
DENTSPLY IH AB
$26
Tempus AI, Inc
$25
Nevro Corp.
$24
ABBVIE INC.
$24
Organon Llc
$23
Laborie Medical Technologies Corp.
$20
Hollister Incorporated
$16
ABC Home Medical Supply, Inc.
$16
Top 3 companies account for 40.9% of 2024 payments
All-time payments by company (2018-2024) ›
Acerus Pharmaceuticals Corporation
$4,701
Astellas Pharma US Inc
$611
Boston Scientific Corporation
$399
Terumo Medical Corporation
$313
Teleflex LLC
$297
SPR Therapeutics, Inc
$210
Evofem Biosciences, Inc.
$202
ABBVIE INC.
$192
Myovant Sciences Inc.
$192
Sumitomo Pharma America, Inc.
$184
Janssen Biotech, Inc.
$177
AngioDynamics, Inc.
$174
Endo Pharmaceuticals Inc.
$174
NeoTract Inc.
$155
BOSTON SCIENTIFIC CORPORATION
$136
Endo USA, Inc.
$125
Aerie Pharmaceuticals, Inc.
$122
Curonix LLC
$118
Nevro Corp.
$107
Coloplast Corp
$101
Daiichi Sankyo Inc.
$98
MAYNE PHARMA INC.
$95
MAYNE PHARMA COMMERCIAL LLC
$86
Agile Therapeutics, Inc.
$81
Myriad Genetic Laboratories, Inc.
$79
DENTSPLY IH AB
$68
Allergan, Inc.
$66
Hologic Sales and Service, LLC
$63
Allergan Inc.
$51
Tolmar, Inc.
$48
Progenics Pharmaceuticals, Inc.
$44
DENTSPLY IH Inc.
$37
180 Medical, Inc.
$31
Phathom Pharmaceuticals, Inc.
$27
Tempus AI, Inc
$25
Olympus America Inc.
$23
Organon Llc
$23
AbbVie Inc.
$23
TherapeuticsMD, Inc.
$23
Exact Sciences Corporation
$21
Laborie Medical Technologies Corp.
$20
Mylan Pharmaceuticals Inc.
$20
Blue Earth Diagnostics Limited
$19
Avadel Specialty Pharmaceuticals, LLC
$19
AbbVie, Inc.
$19
Augmenix, Inc.
$18
Hologic, LLC
$17
Hollister Incorporated
$16
ABC Home Medical Supply, Inc.
$16
Renovia Inc
$16
Antares Pharma, Inc.
$15
Aytu BioScience, Inc
$15
GlaxoSmithKline, LLC.
$14
Top 3 companies account for 57.5% of all-time payments
Associated products mentioned in payments ›
AMS · ANNOVERA · APTIMA · AVEED · AZUR CX DETACHABLE · Axumin · BOTOX · BOTOX THERAPEUTIC · Cologuard Collection Kit · ELIGARD · ERLEADA · Erleada · GEMTESA · GENERAL ERECTILE DYSFUNCTION · HYDROPEARL · INJECTAFER · Imaging · JATENZO · LILETTA · LOFRIC · LUPRON DEPOT · Leva Pelvic Floor Trainer · LoFric · Lupron · MYFEMBREE · MYRBETRIQ · Myrbetriq · NANOKNIFE · NEXPLANON · NEXTSTELLIS · NOCDURNA · Natesto · Noctiva · Omnia · PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A · PROLARIS · PYLARIFY · Phexxi · Prolaris · REZUM · Rhopressa · SHINGRIX · SPECTRA WAVEWRITER · SPRINT PNS System · Senza · SpaceOAR · SpeediCath · TITAN · Twirla · Urgent PC Neuromodulation System · UroLift · UroLift System · VOQUEZNA · VaPro · Varithena Administration Pack · Veozah · XIAFLEX · XTANDI · Xtandi · Xulane · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (51%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an urology physician in New York?
Compare urology physicians in the New York area by procedure volume, costs, and industry payment transparency.
Browse urology physicians nearby

Geographic Context

Urology physicians within 10 mi
727
Per 100K population
44.7
County median income
$104,553
Nearest hospital
BELLEVUE HOSPITAL CENTER
0.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Shusterman is a clinical cardiology specialist, with above-average Medicare volume (top 14% in NY), with low-engagement industry engagement in the top 18% of NY peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Shusterman experienced with urinalysis, manual?
Based on Medicare claims data, Dr. Shusterman performed 684 urinalysis, manual services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Shusterman receive payments from pharmaceutical companies?
Yes. Dr. Shusterman received a total of $9,925 from 53 companies across 174 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Shusterman's costs compare to other urology physicians in New York?
Dr. Shusterman's average Medicare payment per service is $38. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Shusterman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →